1-5 of 5
Suk-hee Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2427: The 5′ endonuclease EEPD1 maintains genomic stability by mediating DNA repair pathway choice

Yuehan Wu, Suk-Hee Lee, Elizabeth A. Williamson, Brian L. Reinert, Gayathri Srinivasan, Sudha Singh, Aruna-Shanker Jaiswal, Silvia Tornaletti, Alexis C. Brantly, Robert A. Hromas
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2427.
https://doi.org/10.1158/1538-7445.AM2014-2427
Published: 01 October 2014
View article titled, Abstract 2427: The 5′ endonuclease EEPD1 maintains genomic stability by mediating DNA repair pathway choice
Journal Articles

Abstract 2125: G-protein coupled receptors for cholecystokinin regulate transactivation of EGF receptors in lung cancer cells

Terry W. Moody, Suk Hee Lee, Paola Moreno Perez, Robert T Jensen
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2125.
https://doi.org/10.1158/1538-7445.AM2014-2125
Published: 01 October 2014
View article titled, Abstract 2125: G-protein coupled receptors for cholecystokinin regulate transactivation of EGF receptors in lung cancer cells
Journal Articles

Targeting the Transposase Domain of the DNA Repair Component Metnase to Enhance Chemotherapy

Elizabeth A. Williamson, Leah Damiani, Andrei Leitao, Chelin Hu, Helen Hathaway, Tudor Oprea, Larry Sklar, Montaser Shaheen, Julie Bauman, Wei Wang, Jac A. Nickoloff, Suk-Hee Lee, Robert Hromas
Journal: Cancer Research
Cancer Res (2012) 72 (23): 6200–6208.
https://doi.org/10.1158/0008-5472.CAN-12-0313
Published: 29 November 2012
View article titled, Targeting the Transposase Domain of the DNA Repair Component Metnase to Enhance Chemotherapy
Open the PDF for Targeting the Transposase Domain of the DNA Repair Component Metnase to Enhance Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Frequent Attenuation of the WWOX Tumor Suppressor in Osteosarcoma Is Associated with Increased Tumorigenicity and Aberrant RUNX2 Expression

Kyle C. Kurek, Sara Del Mare, Zaidoun Salah, Suhaib Abdeen, Hussain Sadiq, Suk-hee Lee, Eugenio Gaudio, Nicola Zanesi, Kevin B. Jones, Barry DeYoung, Gail Amir, Mark Gebhardt, Matthew Warman, Gary S. Stein, Janet L. Stein, Jane B. Lian, Rami I. Aqeilan
Journal: Cancer Research
Cancer Res (2010) 70 (13): 5577–5586.
https://doi.org/10.1158/0008-5472.CAN-09-4602
Published: 30 June 2010
View article titled, Frequent Attenuation of the WWOX Tumor Suppressor in Osteosarcoma Is Associated with Increased Tumorigenicity and Aberrant RUNX2 Expression
Open the PDF for Frequent Attenuation of the WWOX Tumor Suppressor in Osteosarcoma Is Associated with Increased Tumorigenicity and Aberrant RUNX2 Expression in another window
Includes: Supplementary data
Journal Articles

Targeted deletion of Wwox leads to postnatal lethality, impaired steroidogenesis and bone growth retardation

Rami Aqeilan, John Hagan, Stefano Volinia, Francesco Trapasso, Valentina Donati, Dean Marshall, Alain de Bruin, Mohammad Hassan, Sadiq Hussain, Suk-Hee Lee, Gary Stein, Jane Lian, Carlo Croce
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): LB-380.
Published: 01 May 2007
View article titled, Targeted deletion of <em>Wwox</em> leads to postnatal lethality, impaired steroidogenesis and bone growth retardation